Table 4.
Estimated costs of medical resources
| Costs JPY (USD) | Min JPY (USD) | Max JPY (USD) | |
|---|---|---|---|
| Druga | |||
| Aprepitant 125 mg (p.o.) | 4972.7 (45.71) | NA | NA |
| Aprepitant 80 mg (p.o.) | 3393 (31.19) | NA | NA |
| Dexamethasone 1.65 mg (i.v.) | 103 (0.95) | NA | NA |
| Dexamethasone 3.3 mg (i.v.) | 181 (1.66) | NA | NA |
| Dexamethasone 6.6 mg (i.v.) | 335 (3.08) | NA | NA |
| Granisetron 1 mg (i.v.) | 1485 (13.65) | NA | NA |
| Aprepitant regimenb | 15 631.7 (145.24) | 10 492.2 (101.67) | 20 321.2 (188.81) |
| Nonaprepitant regimenb | 4516 (42.12) | 3161.2 (29.48) | 5870.8 (54.75) |
| Rescue medicationb | |||
| Aprepitant group | 849.8 (7.81) | 594.9 (5.47) | 1104.7 (10.15) |
| Nonaprepitant group | 2145.2 (19.72) | 1501.6 (13.80) | 2788.8 (25.63) |
| Medical feesc | |||
| Costs for hospitalization | 25 210 (231.73) | 17 647 (162.21) | 32 773 (301.25) |
| Costs for revisit outpatient | 720 (6.62) | 504 (4.63) | 936 (8.60) |
| Costs for drug prescription (p.o., no more than 6 drugs) | 420 (3.86) | 294 (2.70) | 546 (5.02) |
Exchange rate, 1 USD = 108.79 JPY, based on the Organization for Economic Cooperation and Development (OECD) 2016.27
i.v., intravenous; p.o., oral; NA, not applicable.
a
Japanese National Health Insurance Drug Price Standard listed in 2016.
b
Average costs estimated from the clinical practice in our institution.
c
Japanese National Health Insurance Price listed in 2016.